The global Non-Invasive Cancer Diagnostics market is projected to grow from US$ 116330 million in 2024 to US$ 146340 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.

Non-Invasive Cancer Diagnostics Market

Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.

The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.

Market Analysis and Insights: Global Non-Invasive Cancer Diagnostics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Non-Invasive Cancer Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Non-Invasive Cancer Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-Invasive Cancer Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Invasive Cancer Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Non-Invasive Cancer Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Non-Invasive Cancer Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Non-Invasive Cancer Diagnostics Market Report

Report Metric	Details
Report Name	Non-Invasive Cancer Diagnostics Market
Accounted market size in 2024	US$ 116330 million
Forecasted market size in 2030	US$ 146340 million
CAGR	3.9
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	CTCs CTNAS Exosomes
Segment by Application	Blood Urine Saliva
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gen-Probe Inc, Digene Corporation, Quest Diagnostics Inc, Cancer, Genetics Inc, BIOVIEW Inc, AVIVA Biosciences Corporation, Laboratory Corporation of America Holdings (LabCorp), A&G Pharmaceutical, Affymetrix Inc, Precision Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Non-Invasive Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Invasive Cancer Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Invasive Cancer Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Non-Invasive Cancer Diagnostics Market growing?

Ans: The Non-Invasive Cancer Diagnostics Market witnessing a CAGR of 3.9 during the forecast period 2024-2030.

What is the Non-Invasive Cancer Diagnostics Market size in 2030?

Ans: The Non-Invasive Cancer Diagnostics Market size in 2030 will be US$ 146340 million.

Who are the main players in the Non-Invasive Cancer Diagnostics Market report?

Ans: The main players in the Non-Invasive Cancer Diagnostics Market are Gen-Probe Inc, Digene Corporation, Quest Diagnostics Inc, Cancer, Genetics Inc, BIOVIEW Inc, AVIVA Biosciences Corporation, Laboratory Corporation of America Holdings (LabCorp), A&G Pharmaceutical, Affymetrix Inc, Precision Therapeutics

What are the Application segmentation covered in the Non-Invasive Cancer Diagnostics Market report?

Ans: The Applications covered in the Non-Invasive Cancer Diagnostics Market report are Blood, Urine, Saliva

What are the Type segmentation covered in the Non-Invasive Cancer Diagnostics Market report?

Ans: The Types covered in the Non-Invasive Cancer Diagnostics Market report are CTCs, CTNAS, Exosomes

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 CTCs

1.2.3 CTNAS

1.2.4 Exosomes

1.3 Market by Application

1.3.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Blood

1.3.3 Urine

1.3.4 Saliva

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Invasive Cancer Diagnostics Market Perspective (2019-2030)

2.2 Global Non-Invasive Cancer Diagnostics Growth Trends by Region

2.2.1 Non-Invasive Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-Invasive Cancer Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Non-Invasive Cancer Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Non-Invasive Cancer Diagnostics Market Dynamics

2.3.1 Non-Invasive Cancer Diagnostics Industry Trends

2.3.2 Non-Invasive Cancer Diagnostics Market Drivers

2.3.3 Non-Invasive Cancer Diagnostics Market Challenges

2.3.4 Non-Invasive Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Non-Invasive Cancer Diagnostics by Players

3.1.1 Global Non-Invasive Cancer Diagnostics Revenue by Players (2019-2024)

3.1.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Non-Invasive Cancer Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio

3.4.1 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Cancer Diagnostics Revenue in 2023

3.5 Global Key Players of Non-Invasive Cancer Diagnostics Head office and Area Served

3.6 Global Key Players of Non-Invasive Cancer Diagnostics, Product and Application

3.7 Global Key Players of Non-Invasive Cancer Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Invasive Cancer Diagnostics Breakdown Data by Type

4.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Type (2025-2030)

5 Non-Invasive Cancer Diagnostics Breakdown Data by Application

5.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-Invasive Cancer Diagnostics Market Size (2019-2030)

6.2 North America Non-Invasive Cancer Diagnostics Market Size by Type

6.2.1 North America Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)

6.2.2 North America Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030)

6.2.3 North America Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

6.3 North America Non-Invasive Cancer Diagnostics Market Size by Application

6.3.1 North America Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)

6.3.2 North America Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030)

6.3.3 North America Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

6.4 North America Non-Invasive Cancer Diagnostics Market Size by Country

6.4.1 North America Non-Invasive Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024)

6.4.3 North America Non-Invasive Cancer Diagnostics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Non-Invasive Cancer Diagnostics Market Size (2019-2030)

7.2 Europe Non-Invasive Cancer Diagnostics Market Size by Type

7.2.1 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)

7.2.2 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030)

7.2.3 Europe Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

7.3 Europe Non-Invasive Cancer Diagnostics Market Size by Application

7.3.1 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)

7.3.2 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030)

7.3.3 Europe Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

7.4 Europe Non-Invasive Cancer Diagnostics Market Size by Country

7.4.1 Europe Non-Invasive Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024)

7.4.3 Europe Non-Invasive Cancer Diagnostics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Non-Invasive Cancer Diagnostics Market Size (2019-2030)

8.2 China Non-Invasive Cancer Diagnostics Market Size by Type

8.2.1 China Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)

8.2.2 China Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030)

8.2.3 China Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

8.3 China Non-Invasive Cancer Diagnostics Market Size by Application

8.3.1 China Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)

8.3.2 China Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030)

8.3.3 China Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Non-Invasive Cancer Diagnostics Market Size (2019-2030)

9.2 Asia Non-Invasive Cancer Diagnostics Market Size by Type

9.2.1 Asia Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)

9.2.2 Asia Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030)

9.2.3 Asia Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

9.3 Asia Non-Invasive Cancer Diagnostics Market Size by Application

9.3.1 Asia Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)

9.3.2 Asia Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030)

9.3.3 Asia Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

9.4 Asia Non-Invasive Cancer Diagnostics Market Size by Region

9.4.1 Asia Non-Invasive Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Non-Invasive Cancer Diagnostics Market Size by Region (2019-2024)

9.4.3 Asia Non-Invasive Cancer Diagnostics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Gen-Probe Inc

11.1.1 Gen-Probe Inc Company Details

11.1.2 Gen-Probe Inc Business Overview

11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Introduction

11.1.4 Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.1.5 Gen-Probe Inc Recent Developments

11.2 Digene Corporation

11.2.1 Digene Corporation Company Details

11.2.2 Digene Corporation Business Overview

11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Introduction

11.2.4 Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.2.5 Digene Corporation Recent Developments

11.3 Quest Diagnostics Inc

11.3.1 Quest Diagnostics Inc Company Details

11.3.2 Quest Diagnostics Inc Business Overview

11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Introduction

11.3.4 Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.3.5 Quest Diagnostics Inc Recent Developments

11.4 Cancer, Genetics Inc

11.4.1 Cancer, Genetics Inc Company Details

11.4.2 Cancer, Genetics Inc Business Overview

11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Introduction

11.4.4 Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.4.5 Cancer, Genetics Inc Recent Developments

11.5 BIOVIEW Inc

11.5.1 BIOVIEW Inc Company Details

11.5.2 BIOVIEW Inc Business Overview

11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Introduction

11.5.4 BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.5.5 BIOVIEW Inc Recent Developments

11.6 AVIVA Biosciences Corporation

11.6.1 AVIVA Biosciences Corporation Company Details

11.6.2 AVIVA Biosciences Corporation Business Overview

11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Introduction

11.6.4 AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.6.5 AVIVA Biosciences Corporation Recent Developments

11.7 Laboratory Corporation of America Holdings (LabCorp)

11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details

11.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview

11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Introduction

11.7.4 Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Developments

11.8 A&G Pharmaceutical

11.8.1 A&G Pharmaceutical Company Details

11.8.2 A&G Pharmaceutical Business Overview

11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Introduction

11.8.4 A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.8.5 A&G Pharmaceutical Recent Developments

11.9 Affymetrix Inc

11.9.1 Affymetrix Inc Company Details

11.9.2 Affymetrix Inc Business Overview

11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Introduction

11.9.4 Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.9.5 Affymetrix Inc Recent Developments

11.10 Precision Therapeutics

11.10.1 Precision Therapeutics Company Details

11.10.2 Precision Therapeutics Business Overview

11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Introduction

11.10.4 Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024)

11.10.5 Precision Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Gen-Probe Inc

Digene Corporation

Quest Diagnostics Inc.

Cancer Genetics Inc.

BioView

Aviva Biosciences Corporation

Laboratory Corporation of America Holdings LabCorp

A&G Pharmaceutical

Affymetrix Inc

Precision Therapeutics

List of Tables

Table 1. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of CTCs

Table 3. Key Players of CTNAS

Table 4. Key Players of Exosomes

Table 5. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Non-Invasive Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Non-Invasive Cancer Diagnostics Market Share by Region (2019-2024)

Table 9. Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Non-Invasive Cancer Diagnostics Market Share by Region (2025-2030)

Table 11. Non-Invasive Cancer Diagnostics Market Trends

Table 12. Non-Invasive Cancer Diagnostics Market Drivers

Table 13. Non-Invasive Cancer Diagnostics Market Challenges

Table 14. Non-Invasive Cancer Diagnostics Market Restraints

Table 15. Global Non-Invasive Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Non-Invasive Cancer Diagnostics Revenue Share by Players (2019-2024)

Table 17. Global Top Non-Invasive Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2023)

Table 18. Global Non-Invasive Cancer Diagnostics Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Non-Invasive Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Non-Invasive Cancer Diagnostics, Headquarters and Area Served

Table 21. Global Key Players of Non-Invasive Cancer Diagnostics, Product and Application

Table 22. Global Key Players of Non-Invasive Cancer Diagnostics, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type (2019-2024)

Table 26. Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type (2025-2030)

Table 28. Global Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Non-Invasive Cancer Diagnostics Revenue Share by Application (2019-2024)

Table 30. Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Non-Invasive Cancer Diagnostics Revenue Share by Application (2025-2030)

Table 32. North America Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Non-Invasive Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Non-Invasive Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Non-Invasive Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Non-Invasive Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Non-Invasive Cancer Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Non-Invasive Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Non-Invasive Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 64. Gen-Probe Inc Company Details

Table 65. Gen-Probe Inc Business Overview

Table 66. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product

Table 67. Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 68. Gen-Probe Inc Recent Developments

Table 69. Digene Corporation Company Details

Table 70. Digene Corporation Business Overview

Table 71. Digene Corporation Non-Invasive Cancer Diagnostics Product

Table 72. Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 73. Digene Corporation Recent Developments

Table 74. Quest Diagnostics Inc Company Details

Table 75. Quest Diagnostics Inc Business Overview

Table 76. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product

Table 77. Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 78. Quest Diagnostics Inc Recent Developments

Table 79. Cancer, Genetics Inc Company Details

Table 80. Cancer, Genetics Inc Business Overview

Table 81. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product

Table 82. Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 83. Cancer, Genetics Inc Recent Developments

Table 84. BIOVIEW Inc Company Details

Table 85. BIOVIEW Inc Business Overview

Table 86. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product

Table 87. BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 88. BIOVIEW Inc Recent Developments

Table 89. AVIVA Biosciences Corporation Company Details

Table 90. AVIVA Biosciences Corporation Business Overview

Table 91. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product

Table 92. AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 93. AVIVA Biosciences Corporation Recent Developments

Table 94. Laboratory Corporation of America Holdings (LabCorp) Company Details

Table 95. Laboratory Corporation of America Holdings (LabCorp) Business Overview

Table 96. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product

Table 97. Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 98. Laboratory Corporation of America Holdings (LabCorp) Recent Developments

Table 99. A&G Pharmaceutical Company Details

Table 100. A&G Pharmaceutical Business Overview

Table 101. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product

Table 102. A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 103. A&G Pharmaceutical Recent Developments

Table 104. Affymetrix Inc Company Details

Table 105. Affymetrix Inc Business Overview

Table 106. Affymetrix Inc Non-Invasive Cancer Diagnostics Product

Table 107. Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 108. Affymetrix Inc Recent Developments

Table 109. Precision Therapeutics Company Details

Table 110. Precision Therapeutics Business Overview

Table 111. Precision Therapeutics Non-Invasive Cancer Diagnostics Product

Table 112. Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 113. Precision Therapeutics Recent Developments

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Non-Invasive Cancer Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. CTCs Features

Figure 4. CTNAS Features

Figure 5. Exosomes Features

Figure 6. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Non-Invasive Cancer Diagnostics Market Share by Application: 2023 VS 2030

Figure 8. Blood Case Studies

Figure 9. Urine Case Studies

Figure 10. Saliva Case Studies

Figure 11. Non-Invasive Cancer Diagnostics Report Years Considered

Figure 12. Global Non-Invasive Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Non-Invasive Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Non-Invasive Cancer Diagnostics Market Share by Region: 2023 VS 2030

Figure 15. Global Non-Invasive Cancer Diagnostics Market Share by Players in 2023

Figure 16. Global Top Non-Invasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Non-Invasive Cancer Diagnostics Revenue in 2023

Figure 18. North America Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

Figure 20. North America Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

Figure 21. North America Non-Invasive Cancer Diagnostics Market Share by Country (2019-2030)

Figure 22. United States Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Non-Invasive Cancer Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

Figure 26. Europe Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

Figure 27. Europe Non-Invasive Cancer Diagnostics Market Share by Country (2019-2030)

Figure 28. Germany Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Non-Invasive Cancer Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

Figure 36. China Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

Figure 37. Asia Non-Invasive Cancer Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

Figure 39. Asia Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

Figure 40. Asia Non-Invasive Cancer Diagnostics Market Share by Region (2019-2030)

Figure 41. Japan Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Non-Invasive Cancer Diagnostics Market Share by Country (2019-2030)

Figure 51. Brazil Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Non-Invasive Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Gen-Probe Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 58. Digene Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 59. Quest Diagnostics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 60. Cancer, Genetics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 61. BIOVIEW Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 62. AVIVA Biosciences Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 63. Laboratory Corporation of America Holdings (LabCorp) Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 64. A&G Pharmaceutical Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 65. Affymetrix Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 66. Precision Therapeutics Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions